TN SB1020 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 31 2023 - 25% progression, died in committee
Action: 2023-02-22 - Assigned to General Subcommittee of Senate Health and Welfare Committee
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #2) [PDF]
Status: Introduced on January 31 2023 - 25% progression, died in committee
Action: 2023-02-22 - Assigned to General Subcommittee of Senate Health and Welfare Committee
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, requires a prescribing healthcare practitioner to discuss certain risks associated with a prescribed Schedule II controlled substance prior to an initial prescription and following the third prescription of the drug during a course of treatment; requires the practitioner to document the discussion of such risks in the patient’s medical record. - Amends TCA Title 53 and Title 63.
Title
AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to opioids.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-02-22 | Senate | Assigned to General Subcommittee of Senate Health and Welfare Committee |
| 2023-02-15 | Senate | Placed on Senate Health and Welfare Committee calendar for 2/22/2023 |
| 2023-02-06 | Senate | Passed on Second Consideration, refer to Senate Health and Welfare Committee |
| 2023-02-02 | Senate | Introduced, Passed on First Consideration |
| 2023-01-31 | Senate | Filed for introduction |
Same As/Similar To
HB1501 (Crossfiled) 2023-02-07 - Assigned to s/c Health Subcommittee
